blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1496909

EP1496909 - COMBINATION THERAPY FOR THE TREATMENT OF CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.12.2007
Database last updated on 25.09.2024
Most recent event   Tooltip18.09.2009Lapse of the patent in a contracting state
New state(s): HU, TR		published on 21.10.2009  [2009/43]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[N/P]
Former [2007/07]For all designated states
AstraZeneca AB
S-151 85 Södertälje / SE
Former [2005/03]For:AT  BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IT  LI  LU  MC  PT  RO  SE  SK  TR 
AstraZeneca AB
S-151 85 Södertälje / SE
Inventor(s)01 / RYAN, Anderson, Joseph AstraZeneca R & D Alderley
Alderley Park
Macclesfield Cheshire SK10 4TG / GB
 [2005/03]
Application number, filing date03712464.114.04.2003
[2005/03]
WO2003GB01617
Priority number, dateGB2002000868016.04.2002         Original published format: GB 0208680
GB2002001838808.08.2002         Original published format: GB 0218388
[2005/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03088971
Date:30.10.2003
Language:EN
[2003/44]
Type: A1 Application with search report 
No.:EP1496909
Date:19.01.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 30.10.2003 takes the place of the publication of the European patent application.
[2005/03]
Type: B1 Patent specification 
No.:EP1496909
Date:14.02.2007
Language:EN
[2007/07]
Search report(s)International search report - published on:EP30.10.2003
ClassificationIPC:A61K31/517, A61K31/165, A61P35/00
[2005/03]
CPC:
A61K31/517 (EP,KR,US); A61K31/165 (EP,US); A61K31/661 (KR);
A61P35/00 (EP); A61P43/00 (EP); A61P9/10 (EP)
C-Set:
A61K31/165, A61K2300/00 (EP,US);
A61K31/517, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/03]
Extension statesALNot yet paid
LT16.11.2004
LV16.11.2004
MKNot yet paid
TitleGerman:KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON KREBS[2005/03]
English:COMBINATION THERAPY FOR THE TREATMENT OF CANCER[2005/03]
French:THERAPIE COMBINEE DE TRAITEMENT DU CANCER[2005/03]
Entry into regional phase16.11.2004National basic fee paid 
16.11.2004Designation fee(s) paid 
16.11.2004Examination fee paid 
Examination procedure22.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
16.11.2004Examination requested  [2005/03]
15.03.2005Despatch of a communication from the examining division (Time limit: M02)
04.05.2005Reply to a communication from the examining division
06.03.2006Communication of intention to grant the patent
13.06.2006Fee for grant paid
13.06.2006Fee for publishing/printing paid
Opposition(s)15.11.2007No opposition filed within time limit [2008/04]
Fees paidRenewal fee
02.05.2005Renewal fee patent year 03
02.05.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.02.2007
BE14.02.2007
CY14.02.2007
CZ14.02.2007
DK14.02.2007
EE14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
TR14.02.2007
LU14.04.2007
IE16.04.2007
MC30.04.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
HU15.08.2007
[2009/43]
Former [2009/39]AT14.02.2007
BE14.02.2007
CY14.02.2007
CZ14.02.2007
DK14.02.2007
EE14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
LU14.04.2007
IE16.04.2007
MC30.04.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
Former [2009/34]AT14.02.2007
BE14.02.2007
CY14.02.2007
CZ14.02.2007
DK14.02.2007
EE14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
IE16.04.2007
MC30.04.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
Former [2009/18]AT14.02.2007
BE14.02.2007
CZ14.02.2007
DK14.02.2007
EE14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
IE16.04.2007
MC30.04.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
Former [2009/11]AT14.02.2007
BE14.02.2007
CZ14.02.2007
DK14.02.2007
EE14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
IE16.04.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
Former [2008/25]AT14.02.2007
BE14.02.2007
CZ14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
IE16.04.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
Former [2008/22]AT14.02.2007
BE14.02.2007
CZ14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
BG15.05.2007
GR15.05.2007
PT16.07.2007
Former [2008/04]AT14.02.2007
BE14.02.2007
CZ14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
RO14.02.2007
SI14.02.2007
SK14.02.2007
BG15.05.2007
PT16.07.2007
Former [2008/02]AT14.02.2007
BE14.02.2007
CZ14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
SI14.02.2007
SK14.02.2007
BG15.05.2007
PT16.07.2007
Former [2007/51]AT14.02.2007
BE14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
SI14.02.2007
SK14.02.2007
BG15.05.2007
PT16.07.2007
Former [2007/49]AT14.02.2007
BE14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
SI14.02.2007
BG15.05.2007
PT16.07.2007
Former [2007/47]AT14.02.2007
DK14.02.2007
FI14.02.2007
NL14.02.2007
SI14.02.2007
BG15.05.2007
Former [2007/40]FI14.02.2007
NL14.02.2007
BG15.05.2007
Cited inInternational search[AD]WO9633980  (ZENECA LTD [GB], et al) [AD] 1-12* claims 1-19 *;
 [AD]WO9902166  (ANGIOGENE PHARM LTD [GB], et al) [AD] 1-12 * page 17, line 12 *;
 [A]  - CIARDIELLO F ET AL, "A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.", CLINICAL CANCER RESEARCH: AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. UNITED STATES OCT 2001, (200110), vol. 7, no. 10, ISSN 1078-0432, pages 2958 - 2970, XP002248479 [A] 1-12 * page 2963 - page 2964 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.